Lanean...
Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells
Overexpression and mutational activation of the epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR tyrosine-kinase inhibitors (TKIs) are given as a primary therapy for advanced patients with EGFR-activating mutations; howev...
Gorde:
| Argitaratua izan da: | Mol Pharmacol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407729/ https://ncbi.nlm.nih.gov/pubmed/25724832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.097725 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|